Company Analysis
Sign in

Olema Pharmaceuticals, Inc. (OLMA)

Nasdaq: OLMA · Pharmaceutical Preparations · San Francisco, CA · filing with the SEC since 2018
Full chart Alerts Compare
Grade5.2
◀ Past 5.5● Present 6.0▶ Future 4.2
6 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in December.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019
Report filedMar 16, 2026Mar 18, 2025Mar 11, 2024Mar 9, 2023Feb 28, 2022Mar 17, 2021·
Research and development157,697124,51786,14082,27451,10013,7043,920
General and administrative21,00117,74118,82124,71420,3917,824403
Total operating expenses178,698142,258104,961106,98871,49121,5284,323
Operating income-178,698-142,258-104,961-106,988-71,491-21,528-4,323
Interest expense·····653·
Interest and investment income16,22412,6828,3252,228442607
Other income (expense), net23102-19-27-47··
Total non-operating income (expense)16,24712,7848,3062,201395-5937
Income before income taxes-162,448-129,474·····
Income tax expense3221···
Net income including non-controlling interests-162,451-129,474-96,655-104,787-71,096-22,121-4,316
Net income-162,451-129,474-96,655-104,787-71,096-22,121-4,316
Net income to common shareholders····-71,096-23,990-4,316
Earnings per share, basic-1.87-2.20-2.14-2.62-1.80-3.42-1.66
Earnings per share, diluted-1.87-2.20-2.14-2.62-1.80-3.42-1.66
Weighted average shares, basic87,006,02758,743,52245,247,09839,995,46039,524,2727,021,4682,593,316
Weighted average shares, diluted87,006,02758,743,52245,247,09839,995,46039,524,2727,021,4682,593,316
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton OLMA · research, not advice